OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Clinical and Translational Neurology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	124
The case of a 49‐year‐old man with involuntary toe movements	88
Issue Information	77
The Case of a 25‐Year‐Old Woman With Isolated Head Tremor	51
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	49
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	48
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	46
Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease	46
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	46
Order from chaos: Using CSF proteomics to predict ALS progression	44
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	44
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	43
Dementia Incidence in Individuals With Parkinson's Disease in the Framingham Heart Study	42
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability	42
Peripheral nervous system manifestations of MOG antibody associated disease	42
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	42
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	41
Development of a Prediction Model for Progression Risk in High‐Grade Gliomas Based on Habitat Radiomics and Pathomics	40
Discrepant expressive language lateralization in children and adolescents with epilepsy	40
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab	39
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	39
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐	39
SNUPN ‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights	38
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	38
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	35

Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	35
Cognitive impairment in pulmonary arterial hypertension	35
Association of serum Spp1 levels with disease progression in ALS and SBMA	34
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	34
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	34
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	34
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D	33
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	32
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	32